Deep Track Capital’s Akero Therapeutics AKRO Stock Holding History

Deep Track Capital’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,000,978	Closed	-$190M	–	57
2025 Q3	$190M	Buy	4,000,978 +958,380	+31%	+$46.4M	5.3%	4
2025 Q2	$162M	Sell	3,042,598 -167,672	-5%	-$7.62M	5.21%	6
2025 Q1	$130M	Buy	3,210,270 +1,720,270	+115%	+$72.9M	4.21%	7
2024 Q4	$41.5M	Buy	1,490,000 +800,216	+116%	+$24.2M	1.55%	21
2024 Q3	$19.8M	Buy	+689,784	New	+$18M	0.63%	44
2022 Q4	–	Sell	-790,926	Closed	-$26.9M	–	62
2022 Q3	$26.9M	Buy	+790,926	New	+$12.1M	1.23%	30

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Deep Track Capital's AKRO Position: Q4 2025 in Review

Deep Track Capital sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 4,000,978 shares — an estimated $190M sold.

Deep Track Capital first reported a position in AKRO in Q3 2022 and held it in 6 quarters. The position peaked at $190M in Q3 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

Deep Track Capital reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
Deep Track Capital sold 4,000,978 Akero Therapeutics shares in Q4 2025, an estimated $190M.
Deep Track Capital first reported a position in Akero Therapeutics in Q3 2022 and held it in 6 quarters.
Deep Track Capital's Akero Therapeutics position peaked at $190M in Q3 2025.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Deep Track Capital's 13F filing for Q4 2025, filed 13 Feb 2026.